GSK690693
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK690693, covering 2015-04-17 to 2017-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693 [Phase 1]